The purpose of the study is to investigate the efficacy of cortical gamma oscillation on visual sensory processing and cognitive function in Alzheimer's Disease (AD) patients by combining a therapeutic sensory stimulation device capable of evoking 40-Hz gamma oscillation via non-invasive visual and auditory stimulation with pre-established markers of cortical network activity, i.e., electroencephalography (EEG) and event-related potentials (ERP), to evaluate the applicability of the 40-Hz multimodel sensory stimulation as a novel therapeutic approach for treatment of AD patients.
2 Primary · 1 Secondary · Reporting Duration: 8 weeks
20 Total Participants · 1 Treatment Group
Primary Treatment: AD Patients · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: